Generation of Recombinant Antibodies
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 12 (2) , 173-202
- https://doi.org/10.1385/mb:12:2:173
Abstract
Recombinant antibody technology is opening new perspectives for the development of novel therapeutic and diagnostic agents. In this review we focus on advances in the generation of both genetically engineered humanized and fully human monoclonal antibodies. Methods for their production in different expression systems are also discussed.Keywords
This publication has 96 references indexed in Scilit:
- CDR Walking Mutagenesis for the Affinity Maturation of a Potent Human Anti-HIV-1 Antibody into the Picomolar RangeJournal of Molecular Biology, 1995
- Canonical Structure Repertoire of the Antigen-binding Site of Immunoglobulins Suggests Strong Geometrical Restrictions Associated to the Mechanism of Immune RecognitionJournal of Molecular Biology, 1995
- Comparison of Surface Accessible Residues in Human and Murine Immunoglobulin Fv DomainsJournal of Molecular Biology, 1994
- Structural repertoire of the human VH segmentsJournal of Molecular Biology, 1992
- Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vectorJournal of Molecular Biology, 1991
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Production of antibodies in transgenic plantsNature, 1989
- Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coliNature, 1989
- Canonical structures for the hypervariable regions of immunoglobulinsJournal of Molecular Biology, 1987
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986